Statements of Consolidated Income - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net sales	$ 343.2	$ 371.7
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items	262.0	302.3
Inventory Write-down	4.9	0.0
Unrealized (gain) loss on derivative instruments	(4.0)	4.5
Depreciation and amortization	8.7	8.0
Selling, general, administrative, research and development	26.1	22.7
Net periodic postretirement benefit cost relating to Salaried VEBA	0.8	0.6
(Gain) loss on removal of Union VEBA net assets	(0.1)	492.2
Total selling, general, administrative, research and development	26.8	515.5
Total costs and expenses	298.4	830.3
Operating income (loss)	44.8	(458.6)
Other (expense) income:
Interest expense	(3.7)	(9.8)
Other income, net	0.3	0.4
Income (loss) before income taxes	41.4	(468.0)
Income tax (provision) benefit	(15.1)	175.8
Net income (loss)	$ 26.3	$ (292.2)
Net income (loss) per common share:
Basic	$ 1.47	$ (16.85)
Diluted	$ 1.44	$ (16.85)
Weighted-average number of common shares outstanding (in thousands):
Basic	17,864	17,344
Diluted	18,200	17,344
Common Stock, Dividends, Per Share, Declared	$ 0.45	$ 0.40